Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: Experience from a comprehensive cancer center

被引:0
|
作者
Lee, Y. J. [1 ]
Chung, Y. S. [1 ]
Kim, J. W. [1 ]
Nam, E. J. [1 ]
Kim, S. W. [1 ]
Kim, S. [1 ]
Kim, Y. T. [1 ]
机构
[1] Yonsei Univ, Coll Med, Seoul, South Korea
关键词
D O I
10.1016/j.ygyno.2018.04.367
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
357
引用
收藏
页码:160 / 160
页数:1
相关论文
共 50 条
  • [1] Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
    Lee, Yong Jae
    Chung, Young Shin
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (04)
  • [2] Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
    Mueller, Jennifer J.
    Zhou, Qin C.
    Iasonos, Alexia
    O'Cearbhaill, Roisin E.
    Alvi, Farah A.
    El Haraki, Amr
    Eriksson, Ane Gerda Zahl
    Gardner, Ginger J.
    Sonoda, Yukio
    Levine, Douglas A.
    Aghajanian, Carol
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 436 - 442
  • [3] Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on Survival
    Black, Kristin A.
    Ghosh, Sunita
    Singh, Nilanchali
    Chu, Pamela
    Pin, Sophia
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2021, 43 (12) : 1380 - 1387
  • [4] Neoadjuvant chemotherapy (NACT) selection for advanced stage ovarian cancer (AOC) at a comprehensive cancer center.
    Mueller, Jennifer J.
    Alvi, Farah Abbas
    El Haraki, Amr S.
    Eriksson, Ane Gerda
    Zhou, Qin
    Iasonos, Alexia
    O'Cearbhaill, Roisin Eilish
    Chi, Dennis
    Abu-Rustum, Nadeem
    Zivanovic, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
    Chung, Young Shin
    Kim, Yun-Ji
    Lee, Inha
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    PLOS ONE, 2017, 12 (09):
  • [6] Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer
    Lee, Yong Jae
    Chung, Young Shin
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    GYNECOLOGIC ONCOLOGY, 2018, 148 (01) : 62 - 67
  • [7] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles in patients with advanced ovarian cancer
    Chung, Y. S.
    Lee, J. Y.
    Nam, E. J.
    Kim, S. K.
    Kim, S. W.
    Kim, Y. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 662 - 662
  • [8] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles in patients with advanced ovarian cancer
    Chung, Y. S.
    Eoh, K. J.
    Lee, I.
    Lee, J. Y.
    Nam, E. J.
    Kim, S.
    Kim, S. W.
    Kim, Y. T.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 101 - 102
  • [9] Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer
    Betrian, Sarah
    Angeles, Martina Aida
    Gil Moreno, Antonio
    Cabarrou, Bastien
    Deslandres, Marion
    Ferron, Gwenael
    Mery, Eliane
    Floquet, Anne
    Guyon, Frederic
    Perez-Benavente, Assumpcio
    Spagnolo, Emanuela
    Rychlik, Agnieszka
    Gladieff, Laurence
    Gutierrez, Alicia Hernandez
    Martinez, Alejandra
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (08) : 967 - 974
  • [10] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
    Baruah, Upasana
    Barmon, Debabrata
    Kataki, Amal Chandra
    Deka, Pankaj
    Hazarika, Munlima
    Saikia, Bhargab J.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2015, 36 (01) : 38 - 42